Supply level of the market for vaccines against infectious diseases in swine

This study analyzes the current range of veterinary pharmaceutical products used in the treatment of swine pathologies and evaluates the market conditions for immunoprophylactic drugs. The modern pharmaceutical segment offers a broad spectrum of innovative vaccines and specific sera developed for the prevention and control of diseases in swine farming. High-quality, scientifically validated immunobiological agents are critical for maintaining herd health, improving productivity, and ensuring the biosafety of livestock products. The dynamics of this market reflect not only the diversity of available veterinary therapeutic and preventive products but also their compliance with epidemiological requirements in the context of epizootic risks. The urgency of addressing vaccine shortages in swine farming remains acute, necessitating intensified scientific research into the development of polyvalent and associated vaccines targeting a wide range of pathologies, including infectious atrophic rhinitis in swine, classical swine fever, neonatal diarrhea, rotaviral enteritis in swine, Lawsonia intracellularis infections, streptococcosis, swine enzootic pneumonia, colibacillosis, and porcine circovirus-associated diseases.